Home › NDC Lookup › Ingredients › Famotidine › 69230-0326-60
famotidine 10 mg Tablet, Film Coated, 60-count — NDC 69230-0326-60 package photo

famotidine 10 mg Tablet, Film Coated, 60-count

by Camber Consumer Care Inc · 1 BOTTLE in 1 CARTON (69230-326-60) / 60 TABLET, FILM COATED in 1 BOTTLE
NDC 69230-0326-60
🏷️ FDA NDC (as labeled) 69230-326-60 billing pads the product segment with a zero
This package
Contains60-count Cost per ea$0.0961 NADAC Per package$5.77 / 60 tablets Pack sizes6 compare ↓
Also priced by: Medicaid pays $0.1785/unit · Part D plans $0.0827/unit — full pricing hub ↓
Also comes in: 30 tablets 69230-0326-30 100 tablets 69230-0326-01 500 tablets 69230-0326-05 1000 tablets 69230-0326-10 10000 tablets 69230-0326-33
On market Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Famotidine (different manufacturers) — 2 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Aug 6, 2026 — CGMP Deviations (Baxter Healthcare Corporation) · FDA recall D-0809-2026
Class I · Nov 6, 2025 — Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing. (Fresenius Kabi USA, LLC) · FDA recall D-0182-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

🆔 Identity & classification

FDA NDC (as labeled) 69230-326-60
Product NDC 69230-326
11-digit billing NDC 69230032660
NCPDP billing unit EA — each (per item)
SPL Set ID ebe3ca30-df25-4c56-8935-414a3431b5b9
DEA schedule Non-controlled
Marketing category DRUG FOR FURTHER PROCESSING
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-11-08
Dosage form TABLET, FILM COATED
Substance FAMOTIDINE
GPI-14 49200030000310
GCN Seq No 021688
GCN 46432
HICL code 004521
Ingredient (HICL) Famotidine
HIC1 code Z
Therapeutic class — broad (HIC1) Body As A Whole
HIC2 code Z2
Therapeutic class — intermediate (HIC2) Antihistamines, Antiserotonins, Immunosuppressants
HIC3 code Z2D
Therapeutic class — specific (HIC3) Histamine H2-Receptor Inhibitors
AHFS code 04:92.00.00
AHFS class Other Antihistamines
FDB label name FAMOTIDINE 10 MG TABLET
FDB brand name Famotidine
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 69230-326-60 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 69230-0326-60. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerCamber Consumer Care Inc
Labeler code69230
First marketedNov 2021
Product typeDrug For Further Processing
Portfolio18 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name FAMOTIDINE 10 MG TABLET Ingredient Famotidine
📖 What it is MedlinePlus · NLM

Prescription famotidine is used to treat ulcers (sores on the lining of the stomach or small intestine); gastroesophageal reflux disease (GERD, a condition in which backward flow of acid from the stomach causes heartburn and injury of the esophagus [tube that connects the mouth and stomach]); and conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome (tumors in the pancreas or small intestine that cause increased production of stomach acid). Over-the-counter famotidine is used to prevent and treat heartburn due to acid indigestion and sour stomach caused by eat...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Great question. Antacids (like Tums) neutralize acid that's already in your stomach — they work fast but don't last long. Famotidine is different: it actually blocks a signal in yo...
  • What exactly does famotidine do — and how is it different from antacids?
  • The over-the-counter tablets are meant to relieve heartburn when it happens, or to prevent it if you take them 10 to 60 minutes before a meal that usually causes trouble. You shoul...
  • Can I take the OTC version whenever I have heartburn, or is there a limit?
📖 Read our full Famotidine guide →
6
Nutrient depletion considerations

Famotidine may be associated with lower levels of 6 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Famotidine nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color white / yellow
ShapeRound
ImprintT;11
Size6 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII R12CBM0EIZ
    A natural wax derived from a Brazilian palm tree, used as a coating and polish on tablets and capsules. It creates a smooth, shiny finish that protects the medicine and improves appearance.
  • UNII 9XZ8H6N6OH
    A plant-based cellulose derivative used as a binder to hold tablet ingredients together, a thickener in liquids, and a coating agent to control how fast the medicine dissolves.
  • UNII 36SFW2JZ0W
    Hypromellose 2910 is a plant-based thickening agent derived from cellulose. In medicines, it forms a protective coating on tablets or capsules and controls how quickly the drug dissolves and releases into your body.
  • UNII R75537T0T4
    Hypromellose 2910 is a plant-derived thickening agent made from cellulose. It serves as a binder that holds tablet ingredients together, a film-coating for pills, and a viscosity controller in liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 7T9FYH5QMK
    A plant-derived powder that serves as a binder and filler in tablets and capsules. It helps hold ingredients together, adds bulk, and aids in smooth tablet disintegration when swallowed.
  • UNII PNR0YF693Y
    A plant-based powder made from purified wood cellulose. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in the stomach.
  • UNII 5856J3G2A2
    A starch-based powder made from potatoes and processed with sodium. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the medicine can be absorbed.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

11 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescorn starch, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate and film coating contains carnauba wax, hydroxypropyl cellulose, hypromellose, talc, titanium dioxide; and additionally 20 mg contains iron oxide red and iron oxide yellow.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.096 $5.77 / 60 tablets
Medicaid paysCMS SDUD · 12 mo $0.1785 $10.71 / 60 tablets
Medicare drug plans payPart D · Q2 2026 $0.0827 $4.96 / 60 tablets
NADAC price history (per ea) — tap or hover for the price & month
Dec 2023 Dec 2025 Apr 2026 Aug 2026 $0.109 $0.092
▼ Down 7% over the last 12 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Famotidine 10 mg 70000-0048-01 LEADER/ 30 tablets $0.092 — Availability likely save 4%
good sense acid reducer 10 mg 00113-0141-65 L. 1 tablet $0.096 — Availability likely —
heartburn relief original strength 10 mg 00904-5529-52 Major 60 tablets $0.096 — Availability likely —
Famotidine 10 mg 46122-0735-65 Amerisource 30 tablets $0.096 — Availability likely —
Famotidine 10 mg 68001-0494-04 BluePoint 30 tablets $0.096 — Availability likely —
famotidine 10 mgthis 69230-0326-60 Camber 60 tablets $0.096 — Availability likely —
foster and thrive acid reducer 10 mg 70677-1102-01 Strategic 1 tablet $0.096 — Availability likely —
famotidine 10 mg 83324-0003-30 CHAIN 30 tablets $0.096 — Availability likely —
Acid Controller Original Strength 10 mg 00363-0141-65 Walgreen 1 tablet — — Discontinued —
Famotidine 10 mg 00363-4400-19 WALGREEN 90 tablets — — FDA listed —
Famotidine 10 mg 00363-9607-09 WALGREEN 30 tablets — — FDA listed —
acid relief 10 mg 11822-6141-00 Rite 1 tablet — — FDA listed —
Pepcid AC Original Strength 10 mg 16837-0872-10 Kenvue 10 tablets — — Discontinued —
Famotidine 10 mg 21130-0022-30 Albertsons 30 tablets — — FDA listed —
Famotidine 10 mg 21130-0039-09 Better 30 tablets — — FDA listed —
signature care acid controller 10 mg 21130-0249-65 Safeway 1 tablet — — Discontinued —
Acid Controller 10 mg 21130-0771-75 Safeway 90 tablets — — FDA listed —
Famotidine 10 mg 25000-0086-03 MARKSANS 30 tablets — — FDA listed —
TopCare Acid Reducer 10 mg 36800-0141-65 Topco 1 tablet — — FDA listed —
acid controller 10 mg 37808-0301-65 H 1 tablet — — FDA listed —
Famotidine 10 mg 37835-0161-50 Bi-Mart 50 tablets — — FDA listed —
equaline heartburn prevention 10 mg 41163-0313-65 United 1 tablet — — FDA listed —
Original strength heartburn prevention 10 mg 41226-0719-06 KROGER 30 tablets — — FDA listed —
heartburn relief 10 mg 41250-0493-65 Meijer 1 tablet — — FDA listed —
CareOne Acid Relief 10 mg 41520-0901-65 American 1 tablet — — Discontinued —
acid reducer original strength 10 mg 42507-0141-75 HyVee 90 tablets — — FDA listed —
Acid Reducer Original Strength 10 mg 43598-0824-18 Dr.Reddys 180 tablets — — FDA listed —
Famotidine 10 mg 43602-0511-03 Ascent 300 tablets — — FDA listed —
Equate Famotidine 10 mg 49035-0507-75 Wal-Mart 90 tablets — — FDA listed —
Famotidine 10 mg 49035-0589-19 Wal-Mart 90 tablets — — FDA listed —
Famotidine 10 mg 53943-0100-30 Discount 30 tablets — — FDA listed —
Famotidine 10 mg 54257-0180-07 Magno-Humphries, 90 tablets — — FDA listed —
Famotidine 10 mg 55111-0118-04 Dr. 120 tablets — — FDA listed —
Famotidine 10 mg 55319-0408-01 FAMILY 60 tablets — — FDA listed —
Famotidine 10 mg 55319-0426-60 Family 60 tablets — — FDA listed —
Famotidine 10 mg 55681-0343-03 TWIN 300 tablets — — FDA listed —
dg health heartburn prevention original strength 10 mg 55910-0141-60 Dolgencorp, 1 tablet — — FDA listed —
acid reducer 10 mg 56062-0141-65 Publix 1 tablet — — FDA listed —
Famotidine 10 mg 57896-0317-03 GERI-CARE 30 tablets — — FDA listed —
Famotidine 10 mg 58602-0705-09 Aurohealth 10 tablets — — FDA listed —
Famotidine 10 mg 58602-0828-19 Aurohealth 90 tablets — — FDA listed —
acid controller original strength 10 mg 59779-0141-39 CVS 30 tablets — — FDA listed —
heartburn relief original strength 10 mg 63187-0999-10 Proficient 10 tablets — — FDA listed —
Famotidine 10 mg 63868-0583-30 Chain 30 tablets — — FDA listed —
Famotidine 10 mg 63941-0009-09 Best 30 tablets — — FDA listed —
Famotidine 10 mg 68016-0800-30 Chain 30 tablets — — FDA listed —
Famotidine 10 mg 69256-0002-47 HARRIS 30 tablets — — FDA listed —
Famotidine 10 mg 69842-0063-19 CVS 90 tablets — — FDA listed —
Famotidine 10 mg 69842-0928-84 CVS 30 tablets — — FDA listed —
Famotidine 10 mg 71205-0637-30 Proficient 30 tablets — — FDA listed —
Famotidine 10 mg 71821-0012-08 VKT 288461 tablets — — FDA listed —
basic care acid reducer 10 mg 72288-0141-65 Amazon.com 1 tablet — — FDA listed —
Famotidine 10 mg/10mg 72559-0038-23 Little 300 mg — — FDA listed —
Famotidine 10 mg 72657-0112-20 GLENMARK 200 tablets — — FDA listed —
Welmate Famotidine 10mg 10 mg 73581-0108-09 YYBA 90 tablets — — FDA listed —
Heartburn Relief 10 mg 83059-0005-05 Shield 50 tablets — — FDA listed —
Heartburn Relief 10 mg 83059-0031-05 Shield 50 tablets — — FDA listed —
Famotidine 10 mg 83324-0139-30 Chain 30 tablets — — FDA listed —
Famotidine 10 mg 59651-0112-12 Aurobindo 120000 tablets — — FDA listed —
Famotidine 10 mg 66406-0100-00 Patheon 194174 tablets — — FDA listed —
famotidine 10 mg 66406-0461-00 Patheon 210000 tablets — — FDA listed —
Acid Reducer 10 mg 51316-0816-39 CVS 30 tablets — — FDA listed —
Acid Reducer 10 mg 72288-0756-75 Amazon.com 90 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2021
On the market since
Nov 2021
📍
2026
Currently FDA-listed
5 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 69230-0326-60, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
5.7K
Units reimbursed last 4 qtrs
292.1K
Gross reimbursed last 4 qtrs
$52.1K
Avg / prescription
$9.14
Avg / unit
$0.1785
Latest quarter Q4 2025
1.6KRx
Medicaid pays / ea
$0.1785
gross reimbursed
vs
NADAC / ea
$0.0961
acquisition cost
=
Spread
+$0.0824
+86% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
32% FFS 68% MCO
Fee-for-service · 1,852 Rx Managed care · 3,851 Rx
State Medicaid map
Alaska: no data reported AK Maine: 3,441 units · 247 per 100k residents ME Washington: 42,146 units · 540 per 100k residents WA Idaho: no data reported ID Montana: 1,891 units · 167 per 100k residents MT North Dakota: no data reported ND Minnesota: 7,407 units · 129 per 100k residents MN Wisconsin: no data reported WI Michigan: 18,005 units · 179 per 100k residents MI New York: 39,311 units · 201 per 100k residents NY Vermont: no data reported VT New Hampshire: 5,698 units · 406 per 100k residents NH Oregon: 17,773 units · 420 per 100k residents OR Nevada: 1,558 units · 48.8 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 570 units · 4.5 per 100k residents IL Indiana: 6,077 units · 88.6 per 100k residents IN Ohio: 16,963 units · 144 per 100k residents OH Pennsylvania: 45,660 units · 352 per 100k residents PA New Jersey: 6,611 units · 71.2 per 100k residents NJ Massachusetts: 8,598 units · 123 per 100k residents MA California: 21,257 units · 54.6 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 2,684 units · 136 per 100k residents NE Missouri: no data reported MO Kentucky: 8,939 units · 198 per 100k residents KY West Virginia: no data reported WV Virginia: 12,474 units · 143 per 100k residents VA Maryland: 2,745 units · 44.4 per 100k residents MD Connecticut: 3,223 units · 89.1 per 100k residents CT Rhode Island: 592 units · 54.1 per 100k residents RI Arizona: 8,959 units · 121 per 100k residents AZ New Mexico: no data reported NM Kansas: 444 units · 15.1 per 100k residents KS Arkansas: 1,530 units · 49.9 per 100k residents AR Tennessee: 1,814 units · 25.5 per 100k residents TN North Carolina: no data reported NC South Carolina: 1,226 units · 22.8 per 100k residents SC Delaware: 2,612 units · 253 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 1,873 units · 17.0 per 100k residents GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
4.5540
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Washington 540 /100k
2 Oregon 420 /100k
3 New Hampshire 406 /100k
4 Pennsylvania 352 /100k
5 Delaware 253 /100k
6 Maine 247 /100k
7 New York 201 /100k
8 Kentucky 198 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

💊 Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
60 tablets this page69230-0326-60 5,703 Rx · $52,135
30 tablets69230-0326-30 2,594 Rx · $29,080
100 tablets69230-0326-01 2,391 Rx · $34,730
500 tablets69230-0326-05 1,563 Rx · $18,159
1000 tablets69230-0326-10 1,280 Rx · $50,252
10000 tablets69230-0326-33 No Medicaid data
Drug total (last 4 qtrs): 13,531 Rx · 679,090 units · $184,356 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Famotidine (matched by generic name) — the program that covers self-administered drugs. 29 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Famotidine. CMS lists 2 products for this generic; we show the highest-spend one. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$40.22M
Claims incl. refills
3.8M
Beneficiaries
2.6M
Spend / beneficiary
$15.35
Spend / claim
$10.62
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

📦 Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startStatus
69230-0326-01 1 BOTTLE in 1 CARTON (69230-326-01) / 100 TABLET, FILM COATED in 1 BOTTLE $0.0961 / ea $9.61 2021-11-08 Active
69230-0326-05 1 BOTTLE in 1 CARTON (69230-326-05) / 500 TABLET, FILM COATED in 1 BOTTLE $0.0961 / ea $48.05 2021-11-08 Active
69230-0326-10 1 BOTTLE in 1 CARTON (69230-326-10) / 1000 TABLET, FILM COATED in 1 BOTTLE $0.0961 / ea $96.10 2021-11-08 Active
69230-0326-30 1 BOTTLE in 1 CARTON (69230-326-30) / 30 TABLET, FILM COATED in 1 BOTTLE $0.0961 / ea $2.88 2021-11-08 Active
69230-0326-60 You're viewing this 1 BOTTLE in 1 CARTON (69230-326-60) / 60 TABLET, FILM COATED in 1 BOTTLE $0.0961 / ea $5.77 2021-11-08 Active
69230-0326-33 7 POUCH in 1 DRUM (69230-326-33) / 10000 TABLET, FILM COATED in 1 POUCH — — — Active

This pack effectively ties for the lowest per-ea cost of the 5 priced pack sizes ($0.0961 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 42% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in NDC 69230-0326-60?
NDC 69230-0326-60 is a 60-count package — 1 bottle in 1 carton / 60 tablet, film coated in 1 bottle.
What is the difference between NDC 69230-0326-60 and NDC 69230-0326-30?
Both are famotidine 10 mg Tablet, Film Coated — the drug itself is identical. NDC 69230-0326-60 is the 60-count package, while NDC 69230-0326-30 is the 30 tablets package.
What NDC number is used to bill for this package of famotidine 10 mg Tablet, Film Coated?
Bill NDC 69230-0326-60 — the 11-digit billing format is 69230032660. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

🧭 About this NDC listing & data coverage

Listed for further processing / repackaging

What "drug for further processing" means

FDA lists this package under the "drug for further processing" marketing category: Camber Consumer Care Inc supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) ✓ Available
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 69230-326-60, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 69230-0326-60, written without dashes as 69230032660. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 69230-0326-60, the first segment (69230) is the labeler code FDA assigned to Camber Consumer Care Inc; the middle segment (0326) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (60) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Camber Consumer Care Inc. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 5 other package presentations of this same product, including 30 tablets (69230-0326-30), 100 tablets (69230-0326-01), 500 tablets (69230-0326-05). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Camber Consumer Care Inc is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 31 words ▾

Uses • relieves heartburn associated with acid indigestion and sour stomach • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages

⏱️ Dosage and Administration 105 words ▾

Directions • adults and children 12 years and over: • to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew. 10 mg: • to prevent symptoms, swallow 1 tablet with a glass of water at any time from 15 to 60 minutes before eating food or drinking beverages that cause heartburn 20 mg: • to prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking beverages that cause heartburn • do not use more than 2 tablets in 24 hours • children under 12 years: ask a doctor

⚠️ Warnings 16 words ▾

Warnings Allergy alert: Do not use if you are allergic to famotidine or other acid reducers

🧪 Active Ingredient 12 words ▾

Active ingredient (in each tablet) Famotidine USP 10 mg and 20 mg

🧪 Inactive Ingredients 36 words ▾

Inactive ingredients corn starch, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate and film coating contains carnauba wax, hydroxypropyl cellulose, hypromellose, talc, titanium dioxide; and additionally 20 mg contains iron oxide red and iron oxide yellow.

🎯 Purpose 3 words ▾

Purpose Acid reducer

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 69230-0325-04 · Camber 69230-0327-01 · Camber →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.